Crossmark

Exploring the implementation of patient-reported outcome measures in cancer care: need for more real-world evidence results in the peer reviewed literature

Crossref DOI link: https://doi.org/10.1186/s41687-018-0091-0

Published Online: 2018-12-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anatchkova, Milena

Donelson, Sarah M.

Skalicky, Anne M.

McHorney, Colleen A.

Jagun, Dayo

Whiteley, Jennifer
Funding

Funding for this research was provided by:

Genentech
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 30 March 2018

Accepted: 4 December 2018

First Online: 27 December 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Milena Anatchkova, Anne M. Skalicky, and Colleen A. McHorney are employees of Evidera and received funding from Genentech to conduct the systematic literature review. Jennifer Whiteley is an employee of Genentech, Inc., a member of the Roche Group, and receives stock/options as part of her standard employment compensation.Dayo Jagun and Sarah Donelson were full-time Genentech employees when this study was initiated and completed. Dayo Jagun and Sarah Donelson reviewed and approved the first and all subsequent drafts of the manuscript.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below